4 "

: Montelukast Inovamed 4 Mg. ?  »
|
-

PER OS

Chewable Tablets

Montelukast Inovamed is indicated in pediatric patients 2 to 5 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. Montelukast Inovamed is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Montelukast Inovamed and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Montelukast Inovamed is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 to 5 years of age.

147 29 33181 00

Synthon B.v., Netherlands

01/2012 - 12/2016

.
, .
.
/
Montelukast as sodium 4 MG
Blister al/opa/al/pvc 10 x TABLETS 24
Blister al/opa/al/pvc 20 x TABLETS 24
Blister al/opa/al/pvc 28 x TABLETS 24
Blister al/opa/al/pvc 30 x TABLETS 24
Blister al/opa/al/pvc 50 x TABLETS 24
Blister al/opa/al/pvc 90 x TABLETS 24
Blister al/opa/al/pvc 98 x TABLETS 24
Blister al/opa/al/pvc 100 x TABLETS 24
Blister al/opa/al/pvc 200 x TABLETS 24

*

*

 

.

 
" !
 

?

? B12?  »
60
, -